The Poisson's ratio of a material characterizes its response to uniaxial strain. Materials normally possess a positive Poisson's ratio - they contract laterally when stretched, and expand laterally when compressed. A negative Poisson's ratio is theoretically permissible but has not, with few exceptions of man-made bulk structures, been experimentally observed in any natural materials. Here, we show that the negative Poisson's ratio exists in the low-dimensional natural material black phosphorus and that our experimental observations are consistent with first-principles simulations. Through applying uniaxial strain along armchair direction, we have succeeded in demonstrating a cross-plane interlayer negative Poisson's ratio on black phosphorus for the first time. Meanwhile, our results support the existence of a cross-plane intralayer negative Poisson's ratio in the constituent phosphorene layers under uniaxial deformation along the zigzag axis, which is in line with a previous theoretical prediction. The phenomenon originates from the puckered structure of its in-plane lattice, together with coupled hinge-like bonding configurations.
One of the two isomeric forms of the complex Re2Br4(a-dppm)2(CO) (lb), both of which are formed by the reaction of the triply bonded complex Re2Br4(u-dppm)2 with CO, is shown to have the same A-frame-like stmcture as that characterized previously for RejCLi/t-dppmHCO) (la) by X-ray crystallography. Crystal data for Re2-Br4(M-dppm)2(CO)'CH2Cl2 (lb) at 293 K: monoclinic space group Cc (No. 9) with a = 19.584(5) k,b = 17.109-(2) Á, c = 17.649(6) Á, ß = 105.92(2)°, V = 5686(5) Á3, Z = 4. The structure was refined to R = 0.055 (Rw = 0.073) for 4891 data with I > 3.0 (7). The CO ligand is terminally bound, and the Re-Re distance of 2.336-(1) Á accords with the retention of a Re=Re bond. The second isomeric form of Re2X4(w-dppm)2(CO) has been identified as having an open unsymmetrical structure X3Re(w-dppm)2ReX(CO). The reaction of lb with xylyl and feri-butyl isocyanides produces bioctahedral complexes of the type (RNC)Br2Re(a-dppm)2ReBr2(CO) (R = xylyl (3a), -Bu (3b)), in which two Re-Br bonds are collinear with the Re=Re bond, and the terminally bound RNC and CO ligands are anti to one another on separate Re centers. This structure has been established by a single-crystal X-ray structure determination of 3b. Crystal data for Re2Br4(M-dppm)2(CO)(CN-f-Bu)iCH2-CL^.SCeHe (3b) at 203 K: monoclinic space group P2\ln (No. 14) with a = 12.892(2) Á, b = 19.478(4) Á, c = 27.231(4) ß = 93.623(13)°, V = 6824(4) Á3, Z = 4. The structure was refined to R = 0.066 (Rw = 0.084) for 5166 data with I > 3.0 ( ). The Re-Re distance is 2.381(1) Á. The mixed carbonyl-isocyanide complexes 3a and 3b react with TIO3SCF3 in dichloromethane to give the triply-bonded compounds [RejBnfudppm)2(C0)(CNR)]03SCF3 (R = xylyl (4a), f-Bu (4b)), which have an unsymmetrical structure with the two metal centers possessing different coordination numbers and the CO and RNC ligands trans to one another. This conclusion is based upon a single-crystal X-ray structure determination of 4a. Crystal data for [ReiBrjfMdppm)2(C0)(CNxyl)]03SCF3 (4a) at 293 K: monoclinic space group P2j/c (No. 14) with a = 14.182(3) k,b = 15.749(4) Á, c = 31.580(5) Á, ß = 98.58(2)°, V = 6974(5) Á3, Z = 4. The structure was refined to R = 0.066 (Rw = 0.088) for 5333 data with I > 3.0 ( ). A comparison is made between these results and those obtained previously for the related dirhenium chloro complexes which contain CO and RNC ligands.* Reactions of the Dirhenium(II) Complexes Re2X4(dppm)z (X = Cl, Br; dppm = Ph^PClfiPPlu) with Isocyanides. 7. For part 6, see ref 24.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.